REDWOOD CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will be expanding the scope of a previously approved clinical investigation of fetal heart rate variability […]
